Sucampo Pharmaceuticals, Inc. (SCMP) Tops Q2 EPS by 1c; Updates FY14 GAAP EPS Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Sucampo Pharmaceuticals, Inc. (SCMP) Tops Q2 EPS by 1c; Updates FY14 GAAP EPS Outlook

Sucampo Reports Second Quarter 2014 Financial Results and Corporate Update

August 5, 2014 6:15 AM EDT

Positive Net Income Driven by Strong Revenue Growth in Product Royalty and Product Sales

CEO Peter Greenleaf to Discuss Results of Sucampo's Strategic Review

Company Raises Full Year 2014 Earnings Guidance

Company to host conference call today at 8:30 am Eastern

BETHESDA, Md., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq: SCMP) today reported consolidated financial results for the second quarter and six months ended June 30, 2014. Sucampo reported year... More